Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cushing Syndrome

• Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome
• A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
• Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
• SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
• First-in-human Evaluation of [18F]CETO
• Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
• SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
• An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
• Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
• A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
• Open-label Treatment in Cushing's Syndrome
• Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
• Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
• A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
• Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
• Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition
• A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
• Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
• SOM230 Ectopic ACTH-producing Tumors
• Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
• Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
• Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
• Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
• Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
• Treatment for Endogenous Cushing's Syndrome
• Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
• Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
• An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
• A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
• A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
• Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
• A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
• New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
• Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency